EIR Ventures

Eir Ventures is a life science venture capital firm focused on financing the development of innovative medicine. The firm primarily invests in Series A rounds, with a strong emphasis on the Nordic region as a foundation for leveraging global medical research advancements.

Notable in their portfolio is Pretzel Therapeutics, which has raised a total of $72.5 million. Eir Ventures aims to bridge the gap between cutting-edge medical research and patient care, supporting companies that have the potential to bring transformative treatments to market. Their investment philosophy centers on identifying and nurturing promising life science innovations that can make a significant impact on healthcare outcomes.